#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Uveitis Microvillous inclusion disease Vaginal cancer Small intestine adenocarcinoma Fibrous dysplasia of bone Extra-osseous Ewing's sarcoma Extraskeletal ossification Cystic fibrosis gastrointestinal disease Uterine leiomyosarcoma Anti-myelin-associated glycoprotein associated polyneuropathy Hepatitis B Head and neck cancer Oesophageal achalasia Hypotransferrinaemia Inflammatory myofibroblastic tumour More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Basic Information Congenital generalised lipodystrophy – Basic Information Urea cycle disorder – Diagnostics Rett syndrome – Life with Disease Lymphatic malformation – Treatment Niemann-Pick disease – Treatment Ewing’s sarcoma metastatic – Treatment Malignant fibrous histiocytoma – Treatment Short-bowel syndrome – Diagnostics Chronic granulomatous disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nms-03305293 Interferon Beta-1B Oxygen Ph.eur. Eribulin Mesylate Mva-Hbvac 2,4 DICHLOROBENZYL ALCOHOL Selumetinib Depemokimab Mifepristone IDP-121 X-396 Aceclofenac Metformin Hydrochloride ALE.P03 PRILOCAINE HYDROCHLORIDE Larotrectinib Sulfate Methyl Aminolevulinate Pyridoxine Hydrochloride Bp Pegfilgrastim Desflurane More therapies…

    Learn about Your Condition

    Vitiligo Round cell liposarcoma Erythema Diabetic retinopathy Neuroblastoma recurrent Tubulointerstitial nephritis Ataxia telangiectasia Magnetic resonance imaging Fabry's disease Thyroid disorder Skin wrinkling Osteosarcoma recurrent Kidney transplant rejection Cryoglobulinaemia Hyperoxaluria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Asthma

  • Study of Rocatinlimab compared to Placebo to help adults with Moderate to Severe Asthma

    Not recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Rocatinlimab
    Bulgaria Czechia Hungary Poland Romania

  • Study on the Effects of Dexpramipexole in Adolescents and Adults with Eosinophilic Asthma

    Not recruiting

    3 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dexpramipexole Dihydrochloride Monohydrate
    Poland Romania

  • Study on the Effects of AZD4604 on Airway Inflammation in Adults with Asthma

    Not recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • (2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid
    Denmark Germany Spain

  • Long-term safety study of dexpramipexole tablets in patients with severe eosinophilic asthma who completed EXHALE-2 or EXHALE-3 trials

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dexpramipexole Dihydrochloride Monohydrate
    Bulgaria Czechia Germany Italy Poland Romania +1

  • Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

    Not recruiting

    3 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dexpramipexole Dihydrochloride Monohydrate
    Bulgaria Poland Romania

  • Study of dupilumab added to inhaled corticosteroids and long-acting beta-agonists compared to high-dose inhaled therapy in adolescents and adults with uncontrolled asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Salmeterol
    • Fluticasone Propionate
    • Dupilumab
    Denmark Germany Poland
Previous Page
1 … 7 8 9 10 11 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!